Third, we also explored coexpression with the host cell protease gene TMPRSS2, which revealed many more targets with high druggability and known drug-gene interactions than those related to ACE2. Finally, we used gene expression data from a large lung tissue data set with detailed clinical phenotype information, which allowed us to relate our findings to known risk factors for severe COVID-19. Here, ACE2 is linked to COVID-19.